Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.

Clinical trial NCT00219544 · COMPLETED

Trial details

NCT number: NCT00219544
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2005-11-01
Primary completion: 2008-02-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.